First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer

NCT06934538 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Unresectable Metastatic Colorectal Cancer
Unresectable Locally Advanced Colorectal Cancer

Interventions

BIOLOGICAL: STC-1010 + IS regimen + SOC therapy

Sponsor

Brenus Pharma